Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles

Published:2024-05-22 Issue:10 Volume:16 Page:8998-9022
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Teng Chong¹,Song Xiaowei¹,Fan Chengjuan¹,Man Siqi²,Hu Yuanyuan²,Hou Yifei³,Xin Tao¹

Affiliation:

1. Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

2. Oncology, Harbin Medical University, Harbin, Heilongjiang, China

3. School of Nursing, Harbin Medical University, Harbin, Heilongjiang, China

Publisher

Impact Journals, LLC

Reference56 articles.

1. Awareness and current knowledge of breast cancer.;Khan;Biol Res,2017

2. Breast cancer: Biology, biomarkers, and treatments.;Farahmand;Int Immunopharmacol,2020

3. Research-based PAM50 signature and long-term breast cancer survival.;Natarajan;Breast Cancer Res Treat,2020

4. An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.;Garred;Nat Commun,2019

5. Breast cancer in young women: an overview.;Mitsis;Updates Surg,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP